Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
DTC ads for Opdivo face further backlash
Medical Marketing and Media
Mon, 08/15/16 - 11:11 am
DTC advertising
Opdivo
Bristol-Myers Squibb
AstraZeneca Rides High, Fueled by Brexit, Bristol-Myers Failure
Yahoo/Bloomberg
Fri, 08/12/16 - 11:02 am
AstraZeneca
Brexit
Bristol-Myers Squibb
Opdivo
durvalumab
lung cancer
Bristol-Myers Squibb Co (BMY): How Deep is the Opdivo Wound?
Bidness, ETC
Tue, 08/9/16 - 11:01 pm
Bristol-Myers Squibb
Opdivo
Why Merck’s Lung Cancer Success Won’t Last
Barron's
Tue, 08/9/16 - 10:39 am
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Opdivo bet backfires, creates opening for Merck to pursue DTC
Medical Marketing and Media
Mon, 08/8/16 - 11:18 am
Opdivo
Merck
Bristol-Myers Squibb
Keytruda
DTC advertising
Bristol-Myers' High-Risk Opdivo Lung Cancer Study Shows Challenges Of Clinical Trials
Forbes
Mon, 08/8/16 - 10:07 am
Bristol-Myers Squibb
Opdivo
clinical trials
Is Bristol-Myers' Fall Justified?
Seeking Alpha
Sat, 08/6/16 - 01:06 pm
Bristol-Myers Squibb
Opdivo
Here’s the silver lining inside today’s trial fail for Bristol-Myers' cancer drug
Bizjournals.com
Sat, 08/6/16 - 12:51 pm
Bristol-Myers Squibb
Opdivo
cancer immunotherapy
Bristol-Myers' Opdivo fails key lung cancer study, stocks ricochet
BioPharma Dive
Fri, 08/5/16 - 11:37 am
Bristol-Myers Squibb
Opdivo
Merck Keytruda
non-small cell lung cancer
PD-L1
Bristol-Myers takes a commanding lead over Merck in the first stretch of a blockbuster race
Endpoints
Fri, 07/29/16 - 08:44 pm
Bristol-Myers Squibb
Merck
Keytruda
Opdivo
PDL-1 inhibitors
AbbVie and Bristol-Myers Squibb to collaborate on lung cancer clinical trial
Marketwatch
Mon, 07/25/16 - 10:55 am
AbbVie
Bristol-Myers Squibb
lung cancer
clinical trials
Rova-T
Opdivo
Bristol-Myers Squibb Reveals Regulatory Approvals For Opdivo Marketing Application
Yahoo/Benzinga
Mon, 07/18/16 - 11:07 am
Bristol-Myers Squibb
Opdivo
squamous cell carcinoma of the head and neck
FDA
EMA
UK cost agency rejects Bristol's Opdivo for kidney cancer
Yahoo/Reuters
Tue, 07/5/16 - 10:23 am
UK
Bristol-Myers Squibb
Opdivo
kidney cancer
NICE
Bristol-Myers Squibb Co Wins a Sixth Breakthrough Tag for Opdivo
Bidness, ETC
Tue, 06/28/16 - 05:23 pm
Bristol-Myers Squibb
Opdivo
breakthrough therapies
bladder cancer
FDA
Bristol-Myers Squibb's bladder cancer treatment granted breakthrough therapy designation
Marketwatch
Mon, 06/27/16 - 10:28 am
Bristol-Myers Squibb
bladder cancer
breakthrough therapies
FDA
Opdivo
3 Ways This $30 Billion Market Is Bristol's for the Taking
Motley Fool
Tue, 06/21/16 - 11:16 pm
Bristol-Myers Squibb
immuno-oncology
Opdivo
Will Merck & Co Keytruda Surpass Bristol-Myers Opdivo In Immunotherapies Race?
Bidness, ETC
Fri, 06/17/16 - 10:17 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
cancer immunotherapy
Bristol-Myers’s Drug Combination Boosts Lung Cancer Benefit
Bloomberg
Sat, 06/4/16 - 06:23 pm
Bristol-Myers Squibb
Yervoy
Opdivo
metastatic non-small cell lung cancer
Will Bristol-Myers Squibb Checkmate Colorectal Cancer Now?
Seeking Alpha
Fri, 06/3/16 - 09:50 pm
Bristol-Myers Squibb
colorectal cancer
Opdivo
3 Stories To Watch At The Year’s Biggest Cancer Conference
Investors.com
Mon, 05/30/16 - 06:34 pm
ASCO 2016
Pfizer
Eli Lilly
breast cancer
Ibrance
abemaciclib
AbbVie
non-small cell lung cancer
Rova-T
Keytruda
Bristol-Myers Squibb
Merck
Opdivo
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
next ›
last »